A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants

Brain Research Reviews

Volumn 25, Issue 2, 1997, Pages 192-216

  Pierce, R Christopher ^a   Kalivas, Peter W ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Behavioral sensitization; Dopamine; Drug abuse; Excitatory amino acid; Glutamate; Nucleus accumbens; Prefrontal cortex; Relapse; Schizophrenia; Ventral pallidum; Ventral tegmental area

Indexed keywords

AMPHETAMINE; EXCITATORY AMINO ACID; PSYCHOSTIMULANT AGENT;

BEHAVIOR; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; DRUG EFFECT; HUMAN; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SENSITIZATION; SEROTONINERGIC TRANSMISSION;

AMPHETAMINE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; MODELS, NEUROLOGICAL; NEURONS; NUCLEUS ACCUMBENS; SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS;

EID: 0030813597     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(97)00021-0     Document Type: Review

References (329)

1. Akimoto K., Hamamura T., Kazahaya Y., Akiyama K., Otsuki S. Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine - an in vivo dialysis study in freely moving rats. Brain Res. 507:1990;344-346.
2. Alburges M.E., Narang N., Wamsley J.K. Alterations in dopaminergic receptor system after chronic administration of cocaine. Synapse. 14:1993;314-323.
3. 3H]GBR-12935 binding after chronic treatment with dopamine active drugs. Psychopharmacology. 102:1990;291-294.
4. 1 receptor-containing striatal neurons. Brain Res. 410:1987;1-11.
5. Andersen P.H. The dopamine uptake inhibitor GBR-12909: selectivity and molecular mechanisms of action. Eur. J. Pharmacol. 166:1989;493-504.
6. Angrist B.M., Gershon S. The phenomenology of experimentally induced amphetamine psychosis: preliminary observations. Biol. Psychiat. 2:1970;95-107.
7. Antelman S.M., Chiodo L.A. Dopamine autoreceptor subsensitivity: a mechanism common to the treatment of depression and the induction of amphetamine psychosis. Biol. Psychiat. 16:1981;717-727.
8. Apicella P., Ljungberg T., Scarnati E., Schultz W. Responses to reward in monkey dorsal and ventral striatum. Exp. Brain Res. 85:1991;491-499.
9. Attwell D., Barbour B., Szatkowski M. Nonvesicular release of neurotransmitter. Neuron. 11:1993;401-407.
10. Badiani A., Browman K.E., Robinson T.E. Influence of novel versus home environments on sensitization to the psychomotor stimulant effects of cocaine and amphetamine. Brain Res. 674:1995;291-298.
11. Barnett J.A., Segal D.S., Kuczenski R. Repeated amphetamine pretreatment alters the responsiveness of striatal dopamine-stimulated adenylate cyclase to amphetamine-induced desensitization. J. Pharmacol. Exp. Ther. 242:1990;40-47.
12. 2]Met-enkephalin into the nucleus basalix magnocellularis. Possible interaction with cortical cholinergic projections. Brain Res. 452:1989;203-211.
13. Beitner-Johnson D., Nestler E.J. Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J. Neurochem. 57:1991;344-347.
14. Bell D.S. The experimental reproduction of amphetamine psychosis. Arch. Gen. Psychiat. 29:1973;35-40.
15. Bell K., Kalivas P.W. Context-specific cross sensitization between systemic cocaine and intra-accumbens AMPA infusion in rats. Psychopharmacology. 127:1996;377-383.
16. Benmansour S., Tejani-Butt S.M., Hauptmann M., Brunswick D.J. Lack of effect of high-dose cocaine on monoamine uptake sites in rat brain as measured by quantitative autoradiography. Psychopharmacology. 106:1992;459-462.
17. Berendse H.K., Galis D.E., Graaf Y., Groenewegen H.J. Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat. J. Comp. Neurol. 316:1992;314-367.
18. Berendse H.W., Groenewegen H.J. Organization of the thalamostriatal projections in the rat, with special emphasis on the ventral striatum. J. Comp. Neurol. 299:1990;187-228.
19. K.F. Berman, D.R. Weinberger, Functional localization in the brain in schizophrenia, in: A. Tasman, S.M. Goldfinger, American Psychiatric Press of Review Psychiatry, American Psychiatric Press, Washington, DC, 1991, pp. 24-34.
20. Bhat R.V., Cole A.J., Baraban J.M. Chronic cocaine treatment suppresses basal expression of zif268 in rat forebrain: in situ hybridization studies. J. Pharmacol. Exp. Ther. 263:1992;343-349.
21. Boldry R.C., Willins D.L., Wallace L.J., Uretsky N.J. The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA. Brain Res. 559:1991;100-108.
22. Bonci A., Williams J.T. A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron. 16:1996;631-639.
23. Bonhomme N., Cador M., Stinus L., le Moal M., Spampinato U. Short and long-term changes in dopamine and serotonin receptor binding sites in amphetamine-sensitized rats: a quantitative autoradiographic study. Brain Res. 675:1995;215-223.
24. A.J. Bourdelais, Physiological and pharmacological manipulations of the GABA-ergic pathway between the nucleus accumbens and the ventral pallidum, Wash. St. Univ. Ph. D. Thesis, (1991).
25. Brock J.W., Ng J.P., Justice J.B. Effect of chronic cocaine on dopamine synthesis in the nucleus accumbens as determined by microdialysis perfusion with NSD-1015. Neurosci. Lett. 117:1990;234-239.
26. Brog J.S., Salyapongse A., Deutch A.Y., Zahm D.S. The patterns of afferent innervation of the core and shell in the 'accumbens' part of the ventral striatum: immunohistochemical detection of retrogradely transported Fluoro-Gold. J. Comp. Neurol. 338:1993;255-278.
27. Brown E.E., Robertson G.S., Fibiger H.C. Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: role of forebrain limbic structures. J. Neurosci. 12:1992;4112-4121.
28. 2 dopamine receptors accompanies cocaine-induced behavioral sensitization. Brain Res. 639:1994;228-232.
29. 2+ and secretory-vesicle dynamics. Trends Neurosci. 18:1995;191-196.
30. Cador M., Robbins T.W., Everitt B.J. Involvement of the amygdala in stimulus-reward associations: interaction with the ventral striatum. Neuroscience. 30:1989;77-89.
31. Calabresi P., Pisani A., Mercuri N.B., Bernardi G. Post-receptor mechanisms underlying striatal long-term depression. J. Neurosci. 14:1994;4871-4881.
32. Cameron D.L., Williams J.T. Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J. Neurosci. 14:1994;6763-6767.
33. A. Carlsson, Amphetamine and Related Compounds, Raven Press, New York, 1970, pp. 289-300.
34. Cass W.A., Gerhardt G.A., Gillespie K., Curella P., Mayfield R.D., Zahniser N.R. Reduced clearance of exogenous dopamine in rat nucleus accumbens, but not in dorsal striatum following cocaine challenge in rats withdrawn from repeated cocaine. J. Neurochem. 61:1993;273-283.
35. Castaneda E., Becker J.B., Robinson T.E. The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation evoked striatal dopamine release in vitro. Life Sci. 42:1988;2447-2456.
36. Cerruti C., Pilotte N.S., Uhl G., Kuhar M.J. Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration. Mol. Brain Res. 22:1994;132-138.
37. Cha X.-Y., Pierce R.C., Zuckerman J.B., Kleyman T.R., Kalivas P.W., Mackler S.A. Cocaine alters mRNA levels for the Na/K ATPase pump in vivo and in vitro. Soc. Neurosci. Abstr. 22:1996;1880.
38. Chan P., Di Monte D.A., Luo J.-J., DeLanney L.E., Irwin I., Langston J.W. Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic neurotoxicity. J. Neurochem. 62:1994;2484-2487.
39. Chen J.S., Kelz M.B., Hope B.T., Nakabeppu Y., Nestler E.J. Identity of the chronic FRAs induced by repeated cocaine and electroconvulsive seizure treatments. Soc. Neurosci. Abstr. 26:1996;386.
40. Chergui K., Akaoka H., Charlety P., Suanier C.F., Buda M., Chouvet G. Subthalamic nucleus modulates burst firing of nigral dopamine neurones via NMDA receptors. Neuroreport. 5:1994;1185-1188.
41. Childress A.R., Mozley D., Fitzgerald J., Reivich J., Jaggi J., O'Brien C.P. Limbic activation during cue-induced cocaine craving. Soc. Neurosci. Abstr. 25:1995;1956.
42. 3H]GABA. Neuroscience. 22:1987;425-439.
43. Churchill L., Kalivas P.W. Locomotion stimulated from either the nucleus accumbens or the ventral pallidum is mainly regulated by the ventral tegmental area rather than the mediodorsal thalamus. Soc. Neurosci. Abst. 19:1993;148.
44. Churchill L., Kalivas P.W. A topographically organized GABAergic projection from the ventral pallidum to the nucleus accumbens in the rat. J. Comp. Neurol. 345:1994;579-595.
45. Churchill L., Zahm D.S., Kalivas P.W. The mediodorsal nucleus of the thalamus. I. Forebrain GABAergic innervation Neuroscience. 70:1996;93-102.
46. Clarke P.B.S., Jakubovic A., Fibiger H.C. Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine. Psychopharmacology. 96:1988;511-520.
47. Claye L.H., Akunne H.C., Davis M.D., DeMattos S., Soliman K.F.A. Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration. Mol. Neurobiol. 11:1995;55-65.
48. Cole A.J., Bhat R.V., Patt C., Worley P.F., Barban J.M. D1 dopamine receptor activation of multiple transcription factor genes in rat striatum. J. Neurochem. 58:1992;1420-1426.
49. Cole R.L., Konradi C., Douglass J., Hyman S.E. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron. 14:1995;813-823.
50. P.H. Connell, Amphetamine Psychosis, Chapman and Hill, London, 1958.
51. L.X. Cubeddu, I.S. Hoffmann, R.K. Talmaciu, Is the release of dopamine from medial prefrontal cortex modulated by presynaptic receptors? Comparison with nigrostriatal and mesolimbic terminals, Ann. NY Acad. Sci., (1990) 452-461.
52. Cunningham K.A., Paris J.M., Goeders N.E. Serotonin neurotransmission in cocaine sensitization. Ann. NY Acad. Sci. 654:1992;117-127.
53. Cunningham T., Kelley A.E. Hyperactivity and sensitization to psychostimulants following infusion of choleratoxin into the nucleus accumbens. J. Neurosci. 13:1993;2342-2350.
54. 2 receptor function. Pharmacol. Biochem. Behav. 41:1992;519-525.
55. Daunais J.B., McGinty J.F. Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse. 18:1994;35-45.
56. Delfs J.M., Schreiber L., Kelley A.E. Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat. J. Neurosci. 10:1990;303-310.
57. A.Y. Deutch, A.J. Bourdelais, D.S. Zahm, The nucleus accumbens core and shell: accumbal compartments and their functional attributes, in: P.W. Kalivas, C.D. Barnes (Eds.), Limbic Motor Circuits and Neuropsychiatry, CRC Press, Boca Raton, FL, 1993, pp. 45-88.
58. Deutch A.Y., Clark W.A., Roth R.H. Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res. 521:1990;311-315.
59. Deutch A.Y., Roth R.H. The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog. Brain Res. 85:1990;357-393.
60. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. (USA). 85:1988;5274-5278.
61. Di Chiara G., Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1988;1067-1080.
62. Doherty M.D., Gratton A. Medial prefrontal cortical D1 receptor modulation of the meso-accumbens dopamine response to stress: an electrochemical study in freely behaving rats. Brain Res. 715:1996;86-97.
63. Downs A.W., Eddy N.B. The effect of repeated doses of cocaine on the rat. J. Pharmacol. Exp. Ther. 46:1932;199-202.
64. Y. Dudai, The Neurobiology of Memory, Oxford University Press, Oxford, 1989.
65. Dwoskin L.P., Peris J., Yasuda R.P., Philpott K., Zahniser N.R. Repeated cocaine administration results in supersensitivity of striatal D-2 dopamine autoreceptors to pergolide. Life Sci. 42:1988;255-262.
66. 3H]dopamine release from rat striatal slices by D-2 dopamine receptors. J. Pharmacol. Exp. Ther. 239:1986;442-453.
67. Egan M.F., Wing L., Li R., Kirch D.G., Wyatt R.J. Effects of chronic cocaine treatment on rat brain; long-term reduction in frontal cortical serotonin. Biol. Psychiat. 36:1994;637-640.
68. Ellinwood E.H. Amphetamine psychosis. I. Description of the individuals and process. J. Nerv. Ment. Dis. 144:1967;273-283.
69. Ennulat D.J., Babb S.M., Cohen B.M. Persistent reduction of immediate early gene mRNA in rat forebrain following single or multiple doses of cocaine. Mol. Brain Res. 26:1994;106-112.
70. B.J. Everitt, T.W. Robbins, Amygdala-ventral striatal interactions and reward-related processes, in: J.P. Aggleton (Ed.), The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction, Wiley-Liss, New York, 1992, pp. 401-429.
71. Fallon J.H., Moore R.Y. Catecholamine innervation of basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and striatum. J. Comp. Neurol. 180:1978;545-580.
72. Farfel G.M., Kleven M.S., Woolverton W.L., Seiden L.S., Perry B.D. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkeys. Brain Res. 578:1992;235-243.
73. Feron A., Thierry A.M., Le Dourin C., Glowinski J. Inhibitory influence of the mesocortical dopaminergic system on spontaneous activity or excitatory response induced from the thalamic mediodorsal nucleus in the rat medial prefrontal cortex. Brain Res. 302:1984;257-260.
74. Ferris R.M., Tang F.L.M., Maxwell R.A. A comparison of the capacities of isomers of amphetamine, deoxypipradol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of the rat aorta. J. Pharmacol. Exp. Ther. 181:1972;407-416.
75. 2 autoreceptor sensitivity to pergolide. Brain Res. 541:1991;327-333.
76. L.W. Fitzgerald, E.J. Nestler, Cocaine regulation of signal transduction pathways, in: R.P. Hammer Jr., The Neurobiology of Cocaine, CRC Press, Boca Raton, FL, 1995, pp. 225-246.
77. Fitzgerald L.W., Ortiz J., Hamedani A.G., Nestler E.J. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptions among cross-sensitizing agents. J. Neurosci. 16:1996;274-282.
78. Fontana D.J., Post R.M., Pert A. Conditioned increases in mesolimbic dopamine overflow by stimuli associated with cocaine. Brain Res. 629:1993;31-39.
79. Garcia-Munoz M., Segal D.S., Patino P., Young S.J., Kuczenski R., Groves P.M. Amphetamine-induced changes in nigrostriatal terminal excitability are modified following repeated amphetamine administration. Brain Res. 720:1996;131-138.
80. Garris P.A., Ciolkowski E.L., Pastore P., Wightman R.M. Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J. Neurosci. 14:1994;6084-6093.
81. Gawin F.H. Cocaine addiction: psychology and neurophysiology. Science. 251:1991;1580-1586.
82. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
83. Gifford A.N., Johnson K.M. Effect of chronic cocaine treatment on D2 receptors regulating the release of dopamine and acetylcholine in the nucleus accumbens and striatum. Pharmacol. Biochem. Behav. 41:1992;841-846.
84. Gilbert D.B., Millar J., Cooper S.J. The putative dopamine D3 agonist, 7-OH-DPAT, reduces dopamine release in the nucleus accumbens and electrical self-stimulation to the ventral tegmentum. Brain Res. 681:1995;1-7.
85. Gnegy M.E., Hewlett G.H.K., Yee S.L., Welsh M.J. Alterations in calmodulin content and localization in areas of rat brain after repeated intermittent amphetamine. Brain Res. 562:1991;6-12.
86. Godbout R., Mantz J., Pirot S., Glowinski J., Thierry A.-M. Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization. J. Pharmacol. Exp. Ther. 258:1991;728-738.
87. Goeders N.E., Kuhar M.J. Chronic cocaine administration induces opposite changes in dopamine receptors in the striatum and nucleus accumbens. Alcohol Drug Res. 7:1987;207-216.
88. Goldman-Rakic P.S. Topography of cognition: parallel distributed networks in primate association cortex. Annu. Rev. Neurosci. 11:1988;137-156.
89. Goldstein M., Deutch A.Y. Dopaminergic mechanisms in the pathogenesis of schizophrenia. FASEB J. 6:1992;2413-2421.
90. Gonon F.G. Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience. 24:1988;19-28.
91. Grace A.A., Bunney B.S. The control of firing pattern in nigral dopamine neurons: single spike firing. J. Neurosci. 4:1984;2866-2876.
92. Grace A.A., Bunney B.S. The control of firing pattern in nigral dopamine neurons: burst firing. J. Neurosci. 4:1984;2877-2890.
93. Grace A.A., Bunney B.S. Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Res. 333:1985;271-284.
94. Grant S., London E.D., Newlin D.B., Villemangne V.L., Liu X., Contoreggi C., Phillips R.L., Kimes A.S., Margolin A. Activation of memory circuits during cue-elicited cocaine craving. Proc. Natl. Acad. Sci. (USA). 93:1996;12040-12045.
95. Graybiel A.M. Neurotransmitters and meuromodulators in the basal ganglia. Trends Neurosci. 13:1990;244-254.
96. J.D. Griffith, J.H. Cavanaugh, J. Held, J.A. Oates, Experimental psychosis induced by the administration of d-amphetamine, in: E. Costa, S. Garattini (Eds.), Amphetamines and Related Compounds: Proceedings of the Mario Negri Institute for Pharmacological Research, Milan, Italy, Raven Press, New York, 1970, pp. 897-904.
97. Groenewegen H.J., Berendse H.W. Connections of the subthalamic nucleus with ventral striatopallidal parts of the basal ganglia in the rat. J. Comp. Neurol. 294:1990;607-622.
98. Groenewegen H.J., Berendse H.W., Haber S.N. Organization of the output of the ventral striatopallidal system in the rat: ventral pallidal efferents. Neuroscience. 57:1993;113-142.
99. Groenewegen H.J., Russchen F.T. Organization of the efferent projections of the nucleus accumbens to pallidal, hypothalamic, and mesencephalic structures: a tracing and immunohistochemical study in the cat. J. Comp. Neurol. 223:1984;347-367.
100. Haber S.N., Groenewegen H.J., Grove E.A., Nauta W.J.H. Efferent connections of the ventral pallidum: evidence of a dual striatopallidofugal pathway. J. Comp. Neurol. 235:1985;322-335.
101. Hamamura T., Fibiger H.C. Enhanced stress-induced dopamine release in the prefrontal cortex of amphetamine sensitized rats. Eur. J. Pharmacol. 237:1993;65-71.
102. Haracz J.L., Tschanz J.T., Wang Z., White I.M., Rebec G.V. Striatal single-unit responses to amphetamine and neuroleptics in freely moving rats. Neurosci. Biobehav. Rev. 17:1993;1-12.
103. Heidbreder C.A., Thompson A.C., Shippenberg T.S. Role of extracellular dopamine in the initiation and long term expression of behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 278:1996;490-502.
104. Heidbreder Ch.A., Goldberg S.R., Shippenberg T.S. The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res. 616:1993;335-338.
105. L. Heimer, G.F. Alheid, D.S. Zahm, Basal forebrain organization: an anatomical framework for motor aspects of drive and motivation, in: P.W. Kalivas and C.D. Barnes (Eds.), Limbic Motor Circuits and Neuropsychiatry, CRC Press, Boca Raton, FL, 1993, pp. 1-32.
106. Heimer L., Zahm D.S., Churchill L., Kalivas P.W., Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience. 41:1991;89-125.
107. S.J. Henriksen, J. Giachino, Functional characteristics of nucleus accumbens neurons: evidence obtained from in vivo electrophysiological recordings, in: P.W. Kalivas, C.D. Barnes (Eds.), Limbic Motor Circuits and Neuropsychiatry, CRC Press, Boca Raton, 1993, pp. 101-124.
108. Henry D.J., Greene M.A., White F.J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. J. Pharmacol. Exp. Ther. 251:1989;833-839.
109. 1 dopamine receptor sensitivity within the rat nucleus accumbens. J. Pharmacol. Exp. Ther. 258:1991;882-890.
110. Higashi H., Inanaga K., Nishi S., Uchimura N. Enhancement of dopamine actions on rat nucleus accumbens neurones in vitro after methamphetamine pretreatment. J. Physiol. 408:1989;587-603.
111. Hinson R.E., Poulos C.X. Sensitization to the behavioral effects of cocaine: modification by Pavolvian conditioning. Pharmacol. Biochem. Behav. 15:1981;559-562.
112. Hirabayashi M., Alam M.R. Enhancing effect of methamphetamine on ambulatory activity produced by repeated administration in mice. Pharmacol. Biochem. Behav. 15:1981;925-932.
113. Hitzemann R., Wu J., Hom D., Loh H. Brain locations controlling the behavioral effects of chronic amphetamine intoxication. Psychopharmacology. 72:1980;93-101.
114. Hooks M.S., Duffy P., Striplin C., Kalivas P.W. Behavioral and neurochemical sensitization following cocaine self-administration. Psychopharmacology. 115:1994;265-272.
115. Hooks M.S., Jones G.H., Justice J.B. Jr. Environmental and pharmacological sensitization following repeated administration of systemic or intra-accumbens cocaine. Psychopharmacology. 111:1993;109-116.
116. Hope B., Kosofsky B., Hyman S.E., Nestler E.J. Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc. Natl. Acad. Sci. (USA). 89:1992;5764-5768.
117. Hope B.T., Nye H.E., Kelz M.B., Self D.W., Iadorola M.J., Nakabeppu Y., Duman R.S., Nestler E.J. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron. 13:1994;1235-1244.
118. Horger B.A., Shelton K., Schenk S. Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacol. Biochem. Behav. 37:1990;707-711.
119. Hubner C.B., Koob G.F. The ventral pallidum plays a role in mediating cocaine and heroin self-administration in the rat. Brain Res. 508:1990;20-26.
120. Hurd Y.L., Brown E.E., Finlay J.M., Fibiger H.C., Gerfen C.R. Cocaine self-administration differentially alters mRNA expression of striatal peptides. Mol. Brain Res. 13:1992;165-170.
121. Hurd Y.L., Weiss F., Koob G.F., Ungerstedt U. Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study. Brain Res. 498:1989;199-203.
122. Iwata S., Hewlett G.H.K., Ferrell S.T., Czernik A.J., Meiri K., Gnegy M.E. Increased in vivo phosphorylation state of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine. J. Pharmacol. Exp. Ther. 278:1996;1428-1434.
123. Izenwasser S., Werling L.L., Cox B.M. Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex. Brain Res. 520:1990;303-309.
124. Johnson K., Churchill L., Klitenick M.A., Hooks M.S., Kalivas P.W. Involvement of the ventral tegmental area in locomotion elicited from the nucleus accumbens or ventral pallidum. J. Pharmacol. Exp. Ther. 277:1996;1122-1131.
125. Johnson S.W., North R.A. Two types of neurones in the rat ventral tegmental area and their synaptic inputs. J. Physiol. (Lond.). 450:1992;491-502.
126. Johnson S.W., Seutin V., North R.A. Burst firing in dopamine neurons induced by N-methyl-D-aspartate: role of electrogenic sodium pump. Science. 258:1992;665-667.
127. Jones D.L., Mogenson G.J. Nucleus accumbens to globus pallidus GABA projection: electrophysiological and ionotophoretic investigations. Brain Res. 188:1980;93-105.
128. Jones S.R., Lee T.H., Wightman R.M., Ellinwood E.H. Effects of intermittent and continuous cocaine administration on dopamine release and uptake regulation in the striatum: in vitro voltammetric assessment. Psychopharmacology. 126:1996;331-338.
129. P.W. Kalivas, Neural basis of behavioral sensitization to cocaine, in: R.P. Hammer Jr., The Neurobiology of Cocaine, CRC Press, Boca Raton, 1995, pp. 81-98.
130. P.W. Kalivas and C.D. Barnes, Sensitization in the Nervous System, Telford Press, Caldwell, NJ, 1988.
131. P.W., Kalivas, L. Churchill, M.A. Klitenick, The circuitry mediating the translation of motivational stimuli into adaptive motor responses, in: P.W. Kalivas, C.D. Barnes (Eds.), Limbic Motor Circuits and Neuropsychiatry, CRC Press, Boca Raton, FL, 1993, pp. 237-287.
132. Kalivas P.W., Duffy P. The effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse. 5:1990;48-58.
133. Kalivas P.W., Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J. Neurosci. 13:1993;266-275.
134. Kalivas P.W., Duffy P. D1 receptors modulate glutamate transmission in the ventral tegmental area. J. Neurosci. 15:1995;5379-5388.
135. Kalivas P.W., Duffy P., Barrow J. Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J. Pharmacol. Exp. Ther. 251:1989;378-387.
136. Kalivas P.W., Duffy P., DuMars L.A., Skinner C. Neurochemical and behavioral effects of acute and daily cocaine. J. Pharmacol. Exp. Ther. 245:1988;485-492.
137. Kalivas P.W., Duffy P., Eberhardt H. Modulation of A10 dopamine neurons by GABA agonists. J. Pharmacol. Exp. Ther. 253:1990;858-866.
138. P.W. Kalivas, T. Duffy, Glutamate release in the VTA is altered by repeated cocaine treatments, submitted.
139. Kalivas P.W., Hooks M.S., Sorg B. The pharmacology and neural circuitry of sensitization to psychostimulants. Behav. Pharmacol. 4:1993;315-334.
140. P.W. Kalivas, R.C. Pierce, B.A. Sorg, A role for sensitization in psychostimulant-induced paranoia and psychosis, J. Pharmacol., (1997) in press.
141. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
142. Karler R., Calder L.D., Bedingfield J.B. Cocaine behavioral sensitization and the excitatory amino acids. Psychopharmacology. 115:1994;305-310.
143. Karler R., Calder L.D., Turkanis S.A. DNQX blockade of amphetamine behavioral sensitization. Brain Res. 552:1991;295-300.
144. Karler R., Turkanis S.A., Partlow L.M., Calder L.D. Calcium channel blockers in behavioral sensitization. Life Sci. 49:1991;165-170.
145. Karreman M., Moghaddam B. The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area. J. Neurochem. 66:1996;589-598.
146. Kelly P.H., Iversen S.D. Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur. J. Pharmacol. 40:1975;45-56.
147. 2 receptor function. J. Pharmacol. Exp. Ther. 269:1994;743-749.
148. Kleven M.S., Perry B.D., Woolverton W.L., Seiden L.S. Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain. Brain Res. 532:1990;265-270.
149. Klitenick M.A., Deutch A.Y., Churchill L., Kalivas P.W. Topography and functional role of dopaminergic projections from the ventral mesencephalic tegmentum to the ventral pallidum. Neuroscience. 50:1992;371-386.
150. Klitenick M.A., DeWitte P., Kalivas P.W. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA. J. Neurosci. 12:1992;2623-2632.
151. Kolta M.G., Shreve P., De Souza V., Uretsky N.J. Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology. 24:1985;823-829.
152. Kolta M.G., Shreve P., Uretsky N.J. Effect of pretreatment with amphetamine on the interaction between amphetamine and dopamine neurons in the nucleus accumbens. Neuropharmacology. 28:1989;9-14.
153. Koob G.F. Neuronal mechanisms of drug reinforcement. Ann. NY Acad. Sci. 654:1992;171-191.
154. G.F. Koob, P. Robledo, A. Markou, S.B. Caine, The mescorticolimbic circuit in drug dependence and reward - a role for the extended amygdala? in: P.W. Kalivas, C.D. Barnes (Eds.), Limbic Motor Circuits and Neuropsychiatry, CRC Press, Boca Raton, FL, 1993, pp. 289-310.
155. R. Kuczenski, Biochemical actions of amphetamine and other stimulants, in: I. Creese (Ed.), Stimulants: Neurochemical, Behavioral and Clinical Perspectives, Raven Press, New York, 1983, pp. 31-61.
156. Kuczenski R., Segal D.S. In vivo measures of monoamines during amphetamine-induced behaviors in rats. Prog. Neuro.-Psychopharmacol. Biol. Psych. 14(Suppl.):1990;S37-S50.
157. M.J. Kuhar, N.S. Pilotte, Neurochemical changes in cocaine withdrawal, Trends Pharmacol. Sci., 17 (1996).
158. Kula N.S., Baldessarini R.J. Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine. Neuropharmacology. 30:1991;89-92.
159. Kuroda M., Ojima H., Igarashi H., Murakami K., Okada A., Masataka S. Synaptic relationships between axon terminals from the mediodorsal thalamic nucleus and layer III pyramidal cells in the prelimbic cortex of the rat. Brain Res. 708:1996;185-190.
160. B and dopamine receptors in rat substantia nigra neurones. J. Physiol. 401:1988;437-454.
161. Laruelle M., Abi-Dargham A., van Dyck C.H., Gil R., D'Souza C.D., Erdos J., McCance E., Rosenblatt W., Fingado C., Zoghbi S.S., Baldwin R.M., Seibyl J.P., Krystal J.H., Charney D.S., Innis R.B. Single photon emmission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. Natl. Acad. Sci. (USA). 93:1996;9235-9240.
162. le Moal M., Simon H. Mesocorticolimbic dopaminergic network: functional and regulator roles. Physiol. Rev. 71:1991;155-234.
163. Lett B.T. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine and cocaine. Psychopharmacology. 98:1989;357-362.
164. Li M.-Y., Yan Q.-S., Coffey L.L., Reith M.E.A. Extracellular dopamine, norepinephrine, and serotonin in the nucleus accumbens of freely moving rats during intracerebral dialysis with cocaine and other monoamine uptake blockers. J. Neurochem. 66:1996;559-568.
165. Li S.J., Sivam S.P., McGinty J.F., Jiang H.K., Douglass J.C.L., Hong J.S. Regulation of the metabolism of striatal dynorphin by the dopaminergic system. J. Pharmacol. Exp. Ther. 246:1988;403-408.
166. Y. Li, A.J. Vartanian, F.J. White, C.-J. Xue, M.E. Wolf, Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine, J. Pharmacol. Exp. Ther., (1997) (In Press).
167. Li Y., Wolf M.E. Ibotenic acid lesions of the prefrontal cortex do not prevent the expression of behavioral sensitization to amphetamine. Behav. Brain Res. 84:1997;285-289.
168. Lieberman J.A., Kinon B.J., Loebel A.D. Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schiz. Bull. 16:1990;97-110.
169. Lien R., Mishra O.M., Graham E., Delivoria-Papadopoulos M., Andlay E.K. Alteration of brain cell membrane function following cocaine exposure in fetal guinea pig. Brain Res. 637:1994;249-254.
170. B.K. Lipska, D.R. Weinberger, Cortical regulation of the mesolimbic dopamine system: implications for schizophrenia, in: P.W. Kalivas, C.D. Barnes (Eds.), Limbic Motor Circuits and Neuropsychiatry, CRC Press, Boca Raton, FL, 1993, pp. 329-350.
171. Lisman J. The CaM kinase II hypothesis for the storage of synaptic memory. Trends Neurosci. 17:1994;406-412.
172. Louilot A., le Moal M., Simon H. Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens. An in vivo votammetric study. Neuroscience. 29:1989;45-56.
173. Lu W., Chen H., Xue C.-J., Wolf M.E. Repeated amphetamine administration alters the expression of mRNA for AMPA receptor subunits in rat nucleus accumbens and prefrontal cortex. Synapse. 26:1997;269-280.
174. X.-Y. Lu, B. Ghazemzadeh, P.W. Kalivas, Expression of D1,D2, substance P and enkephalin mRNAs in the neurons projecting from the nucleus accumbens, Neuroscience, (1997) (In Press).
175. Lyer R.N., Bradberry C.W. Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization. J. Pharmacol. Exp. Ther. 277:1996;40-47.
176. Maldonado-Irizarry C.S., Swanson C.J., Kelley A.E. Glutamate receptors in the nucleus accumbens shell conrol feeding behavior via the lateral hypothalmus. J. Neurosci. 15:1995;6779-6788.
177. Mark G.P., Blander D.S., Hoebel B.G. A conditioned stimulus decreases extracellular dopamine content in the nucleus accumbens after the development of a learned taste aversion. Brain Res. 551:1991;308-310.
178. Markou A., Koob G.F. Post cocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology. 4:1991;17-26.
179. Martin-Iverson M.T., Reimer A.R. Effects of nimodipine and/or haloperidol on the expression of conditioned locomotion and sensitization to cocaine in rats. Psychopharmacology. 114:1994;315-320.
180. 2-receptor mechanisms. Neurosci. Lett. 217:1996;73-76.
181. 1 dopamine receptor function in rat nucleus accumbens and striatum. Brain Res. 573:1992;331-335.
182. Mayford M., Bach M.E., Huang Y.-Y., Wang L., Hawkins R.D., Kandel E.R. Control of memory formation through regulated expression of a CaMKII transgene. Science. 274:1996;1678-1683.
183. McAlonan G.M., Robbins T.W., Everitt B.J. Effects of medial dorsal thalamic and ventral pallidal lesions on the acquisition of a conditioned place preference: further evidence for the involvement of the ventral striatopallidal system in reward-related processes. Neuroscience. 52:1993;605-620.
184. Meiergerd S.M., Hooks M.S., Schenk J.O. The striatal transporter for dopamine in the rat may be kinetically up-regulated following three weeks of withdrawal from self-administration. J. Neurochem. 63:1994;1277-1281.
185. Meiergerd S.M., McElvain J.S., Schenk J.O. Effects of cocaine and repeated cocaine followed by withdrawal: alterations of dopaminergic transporter turnover with no change in kinetics of substrate recognition. Biochem. Pharmacol. 47:1994;1627-1634.
186. Meredith G.E., Pennartz C.M.A., Groenewegen H.J. The cellular framework for chemical signalling in the nucleus accumbens. Prog. Brain Res. 99:1993;3-24.
187. Miserendino M.J., Nestler E.J. Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens. Brain Res. 674:1995;299-306.
188. Mishkin M., Appenzeller T. The anatomy of memory. Sci. Amer. 256:1987;62-71.
189. Mitchell J.B., Gratton A. Opioid modulation and sensitization of dopamine release elicited by sexually relevant stimuli: a high-speed chronoamperometric study in freely behaving rats. Brain Res. 551:1990;20-27.
190. G.J. Mogenson, Limbic-motor integration, in: A.N. Epstein and A.R. Morrison (Eds.), Progress in Psychobiology and Physiological Psychology, Academic Press, New York, 1987, pp. 117-170.
191. G.J. Mogenson, S.M. Brudzynski, M. Wu, C.R. Yang, C.C.Y. Yim, From motivation to action: a review of dopaminergic regulation of limbic- nucleus accumbens- pedunculopontine nucleus circuitries involved in limbic-motor integration, in: P.W. Kalivas, C.D. Barnes (Eds.), Limbic Motor Circuits and Neuropsychiatry, CRC Press, Boca Raton, FL, 1993, pp. 193-236.
192. Mogenson G.J., Swanson L.W., Wu M. Evidence that projections from the substantia innominata to zona incertal and mesencephalic locomotor region contribute to locomotor activity. Brain Res. 334:1985;65-76.
193. Moghaddam B., Gruen R.J. Do endogenous excitatory amino acids influence striatal dopamine release? Brain Res. 544:1991;329-330.
194. Montaron M.F., Deniau J.M., Menetrey A., Glowinski J., Thierry A.M. Prefrontal cortex inputs of the nucleus accumbens-nigro-thalamic circuit. Neuroscience. 71:1996;371-382.
195. Moratalla R., Elibol B., Vallejo M., Graybiel A.M. Network-level changes in expression of inducible fos-jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron. 17:1996;147-156.
196. Murase S., Grenoff J., Chouvet G., Gonon F.G., Svensson T.H. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studies in vivo. Neurosci. Lett. 157:1993;53-56.
197. T.C. Napier, Transmitter actions and interactions on pallidal neuronal function, in: P.W. Kalivas, C.D. Barnes (Eds.), Limbic Motor Circuits and Neuropsychiatry, CRC Press, Boca Raton, FL, 1993, pp. 125-154.
198. T.C. Napier, M.B. Muench, R.J. Maslowski, G. Battaglia, Is dopamine a neurotansmitter within the ventral pallidum/substantia innominata? in: T.C. Napier, P.W. Kalivas, I. Hanin (Eds.), The Basal Forebrain: Anatomy to Function, Plenum Press, New York, 1991, pp. 183-196.
199. oa in discrete regions of rat brain. J. Neurochem. 55:1990;1079-1082.
200. Ng J.P., Hubert G.W., Justice J.B. Jr. Increased stimulated release and uptake of dopamine in the nucleus accumbens after repeated cocaine administration as measured by in vivo voltammetry. J. Neurochem. 56:1991;1485-1492.
201. Nguyen T.V., Kosofsky B.E., Birnbaum R., Cohen B.M., Hyman S.E. Differential expression of c-Fos and Zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. Natl. Acad. Sci. (USA). 89:1992;4270-4274.
202. Nicholls D.G. The glutaminergic nerve terminal. Eur. J. Biochem. 212:1993;613-631.
203. Nye H.E., Hope B.T., Kelz M.B., Iadorola M., Nestler E.J. Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens. J. Pharmacol. Exp. Ther. 275:1995;1671-1680.
204. O'Brien C.P., Childress A.R., McLellan A.T., Ehrman R. Classical conditioning in drug-dependent humans. Ann. NY Acad. Sci. 654:1992;400-415.
205. Olmstead M.C., Franklin K.B. Lesions of the pedunculopontine tegmental nucleus block drug-induced reinforcement but not amphetamine-induced locomotion. Brain Res. 638:1994;29-35.
206. Pani L., Carboni S., Kusmin A., Gessa G.L., Rossetti Z.L. Nimodipine inhibits cocaine-induced dopamine release and motor stimulation. Eur. J. Pharmacol. 176:1990;245-246.
207. Parsons L.H., Justice J.B. Jr. Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area and dorsal raphe nucleus following repeated cocaine administration. J. Neurochem. 61:1993;1611-1619.
208. Parsons L.H., Justice J.B. Jr. Quantitative approaches to in vivo brain microdialysis. Critical Rev. Neurobiol. 8:1994;189-220.
209. Parsons L.H., Smith A.D., Justice J.B. Jr. Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse. 9:1991;60-65.
210. Patrick S.L., Thompson T.L., Walker J.M., Patrick R.L. Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus. Brain Res. 538:1991;343-346.
211. Paulson P.E., Robinson T.E. Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse. 19:1995;56-65.
212. Pehek E.A. Local infusion of the serotonin antagonists ritanserin or ICS 205,903 increases in vivo dopamine release in the rat prefrontal cortex. Synapse. 24:1996;12-18.
213. Pennartz C.M.A., Groenewegen H.J., Lopes da Silva F.H. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an intergration of behavioral, electrophysiological and anatomical data. Prog. Neurobiol. 42:1994;719-761.
214. Pennartz C.M.A., Kitai S.T. Hippocampal inputs to identified neurons in an in vitro slice preparation of the rat nucleus accumbens: evidence for feed-forward inhibition. J. Neurosci. 11:1991;2838-2847.
215. Peris J., Boyson S.J., Cass W.A., Curella P., Dwoskin L.P., Larson G., Lin L.-H., Yasuda R.P., Zahniser N.R. Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J. Pharmacol. Exp. Ther. 253:1990;38-44.
216. Persico A.M., Schindler C.W., O'Hara B.F., Brannock M.T., Uhl G.R. Brain transcription factor expression: effects of acute and chronic amphetamine and injection stress. Mol. Brain Res. 20:1993;91-100.
217. A. Pert, R. Post, S.R.B. Weiss, Conditioning as a critical determinant of sensitization induced by psychomotor stimulants, in: L. Erinoff (Ed.), Neurobiology of Drug Abuse: Learning and Memory, NIDA, Washington, DC, 1992, pp. 208-241.
218. Perugini M., Vezina P. Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J. Pharmacol. Exp. Ther. 270:1994;690-696.
219. Perugini M., Vezina P. Lack of sensitization to the locomotor effects of direct D-1 receptor agonists in rats having been exposed to amphetamine. Soc. Neurosci. Abstr. 20:1994;825.
220. Pettit H.O., Pan H.-T., Parsons L.H., Justice J.B. Jr. Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. J. Neurochem. 55:1990;798-804.
221. Phillipson O.T., Griffiths A.C. The topographic order of inputs to the nucleus accumbens in the rat. Neuroscience. 16:1985;275-296.
222. Piazza P.V., Deminiere J.M., le Moal M., Simon H. Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res. 514:1990;22-26.
223. Pierce R.C., Bell K., Duffy P., Kalivas P.W. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J. Neurosci. 16:1996;1550-1560.
224. Pierce R.C., Duffy P., Kalivas P.W. Sensitization to cocaine and dopamine autoreceptor subsensitivity in the nucleus accumbens. Synapse. 20:1995;33-36.
225. R.C. Pierce, P. Duffy, P.W. Kalivas, Changes in excitatory amino acid transmission in the nucleus accumbens associated with behavioral sensitization to cocaine during early withdrawal, Neurosci. Net, article #1008 (1996).
226. R.C. Pierce, J. Hicks, D. Reeder, Z.R. Morgan, P.W. Kalivas, Bilateral ibotenic acid lesions of the dorsal prefrontal cortex block the expression of behavioral sensitization to cocaine, Neuroscience (1997), in press.
227. Pierce R.C., Kalivas P.W. Amphetamine produces sensitized locomotion and dopamine release preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J. Pharmacol. Exp. Ther. 275:1996;1019-1029.
228. Pierce R.C., Kalivas P.W. Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J. Neurosci. 17:1997;3254-3261.
229. Pilotte N.S., Sharpe L.G., Kuhar M.J. Withdrawal from repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. J. Pharmacol. Exp. Ther. 269:1994;963-969.
230. Post R.M. Cocaine psychosis: a continuum model. J. Psychiatry. 132:1975;225-231.
231. Post R.M., Lockfeld A., Squillace K.M., Contel N.R. Drug environment interaction: context dependency of cocaine induced behavioral sensitization. Life Sci. 28:1981;755-760.
232. Post R.M., Rose H. Increasing effects of repetitive cocaine administration in the rat. Nature (London). 260:1976;731-732.
233. R.M. Post, S.R.B. Weiss, Sensitization and kindling: implications for the evolution of psychiatric symptomatology, in: P.W. Kalivas, C.D. Barnes (Eds.), Sensitization in the Nervous System, Telford Press, Caldwell, NJ, 1988, pp. 257-292.
234. R.M. Post, S.R.B. Weiss, A. Pert, T.W. Uhde, Chronic cocaine administration: sensitization and kindling effects, in: S. Risher, A. Raskin, E.H. Uhlenhuth (Eds.), Cocaine: Clinical and Behavioral Aspects, Oxford University Press, New York, 1987, pp. 109-173.
235. Pulvirenti L., Berrier R., Kreifeldt M., Koob G.F. Modulation of locomotor activity by NMDA receptors in the nucleus accumbens core and shell regions of the rat. Brain Res. 664:1994;231-236.
236. Randrup A., Munkvad I. Brain dopamine and amphetamine induced stereotyped behavior. Acta Pharmacol. Toxicol. 25(Suppl. 4):1967;60-62.
237. Reid M.S., Berger S.P. Evidence for sensitization of cocaine-induced nucleus accumbens glutamate release. Neuroreport. 7:1997;1325-1329.
238. Reith M.E.A., Meisler B.E., Sershen H., Lajtha A. Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem. Pharmacol. 35:1986;1123-1129.
239. Reith M.E.A., Selmeci G. Cocaine binding sites in mouse striatum, dopamine autoreceptors, and cocaine-induced locomotion. Pharmacol. Biochem. Behav. 41:1992;227-230.
240. Ritz M.C., Cone E.J., Kuhar M.J. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci. 46:1990;635-645.
241. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223.
242. Robertson M.W., Leslie C.A., Bennett J.P. Jr. Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment. Brain Res. 538:1991;337-340.
243. Robinson T.E., Becker J.B. Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur. J. Pharmacol. 85:1982;253-254.
244. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
245. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18:1993;247-291.
246. Robinson T.E., Jurson P.A., Bennett J.A., Bentgen K.M. Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res. 462:1988;211-222.
247. Rosen J.B., Chuang E., Iadarola M.J. Differential induction of fos protein and a fos-related antigen following acute and repeated cocaine administration. Mol. Brain Res. 25:1994;168-1721.
248. Rosetti Z.L., Melis F., Carboni S., Gessa G.L. Dramatic depletion of mesolimbic extracellular dopamine after withdrawal from morphine, alcohol or cocaine: a common neurochemical substrate for drug dependence. Ann. NY Acad. Sci. 654:1992;513-516.
249. Roth R.H. Dopamine autoreceptors: distribution, pharmacology and function. Ann. NY Acad. Sci. 430:1984;27-53.
250. Sato M., Chen C.-C., Akiyama K., Otsuki S. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol. Psychiat. 18:1983;429-440.
251. Schultz W., Apicella P., Scarnati E., Ljungberg T. Neuronal activity in monkey ventral striatum related to the expectation of reward. J. Neurosci. 12:1992;4595-4606.
252. Schweizer F.E., Betz H., Augustine G.J. From vesticle docking to endocytosis: intermediate reactions of exocytosis. Neuron. 14:1995;689-696.
253. Segal D.S., Kuczenski R. Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res. 577:1992;351-355.
254. Segal D.S., Kuczenski R. In vivo microdialysis reveals a diminished amphetamine-induced dopamine response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res. 521:1992;330-332.
255. Segal D.S., Mandell A.J. Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol. Biochem. Behav. 2:1974;249-255.
256. D.S. Segal, M.A. Schuckit, Animal models of stimulant-induced psychosis, in: I. Creese (Ed.), Stimulants: Neurochemical, Behavioral, and Clinical Perspectives, Raven Press, New York, 1983, pp. 131-167.
257. Seiden L.S., Sabol K.E., Ricuarte G.A. Amphetamine: effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 33:1993;639-677.
258. Sesack S.R., Bressler C.N., Lewis D.A. Ultrastructural association between dopamine terminal and local circuit neurons in the monkey prefrontal cortex: a study of calretinin-immunoreactive cells. Neurosci. Lett. 200:1995;9-12.
259. Sesack S.R., Deutch A.Y., Roth R.H., Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J. Comp. Neurol. 290:1989;213-242.
260. Sesack S.R., Pickel V.M. In the medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res. 527:1990;266-272.
261. Sesack S.R., Pickel V.M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J. Comp. Neurol. 320:1992;145-160.
262. Seutin V., Johnson S.W., North R.A. Effect of dopamine and baclofen on N-methyl-D-aspartate-induced burst firing in rat ventral tegmental neurons. Neuroscience. 58:1994;201-206.
263. Sharp T., Zetterstrom T., Ljungberg T., Ungerstedt U. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res. 401:1987;322-330.
264. 3H] mazindol-labelling of dopamine transporter in rat nucleus accumbens. Eur. J. Pharmacol. 203:1991;141-144.
265. Silvam S.P. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J. Pharmacol. Exp. Ther. 256:1989;818-824.
266. Simpson J.N., Wang J.Q., McGinty J.F. Repeated amphetamine administration induces a prolonged augmentation of phosphorylated cyclase response element-binding protein and Fos-related antigen immunoreactivity in rat striatum. Neuroscience. 69:1995;441-457.
267. Smiley P.L., Johnson M., Bush L., Gibb J.W., Hanson G.R. Effects of cocaine on extrapyramidal and limbic dynorphin systems. J. Pharmacol. Exp. Ther. 253:1990;938-943.
268. Snyder S.H. Amphetamine psychosis: a 'model' schizophrenia mediated by catecholamines. Am. J. Psychiatry. 130:1973;61-67.
269. Sorg B.A., Chen S.-Y., Kalivas P.W. Time course of tyrosine hydroxylase expression following behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 266:1993;424-430.
270. B.A. Sorg, D.L. Davison, P.W. Kalivas, B.M. Prasad, Repeated daily cocaine suppresses subsequent cocaine-induced increase of extracellular dopamine in the medial prefrontal cortex, J. Pharmacol. Exp. Ther., (1997) (In Press).
271. Sorg B.A., Kalivas P.W. Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex. Neuroscience. 53:1993;695-703.
272. Spangel R., Herz A., Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. (USA). 89:1992;2046-2050.
273. Starr M.S., Starr B.S. Circling evoked by intranigral SKF 38393: a GABA-mediated D-1 response? Pharmacol. Biochem. Behav. 32:1989;849-851.
274. Stefurak T.L., van der Kooy D. Tegmental pedunculopotine lesions in rats decrease saccharin's rewarding effects but not its memory-improving effect. Behav. Neurosci. 108:1994;972-980.
275. Steiner H., Gerfen C.R. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J. Neurosci. 13:1993;5066-5081.
276. J. Stewart, P. Vezina, Conditioning and behavioral sensitization, in: P.W. Kalivas, C.D. Barnes (Eds.), Sensitization in the Nervous System, Telford Press, Caldwell, NJ, 1988, pp. 207-224.
277. Striplin C., Kalivas P.W. Robustness of G protein changes in cocaine sensitization shown with immunoblotting. Synapse. 14:1993;10-15.
278. Striplin C.D., Kalivas P.W. Correlation between behavioral sensitization to cocaine and G protein ADP-ribosylation in the ventral tegmental area. Brain Res. 579:1992;181-186.
279. Suaud-Chagny M.F., Chergui K., Chouvet G., Gonon F. Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area. Neuroscience. 49:1992;63-72.
280. Swanson L.W. The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 9:1982;321-353.
281. Swerdlow N.R., Koob G.F. Dopamine, schizophrenia, mania and depression: toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behav. Brain Sci. 10:1987;197-245.
282. Swerdlow N.R., Swanson L.W., Koob G.F. Substantia innominata: critical link in the behavioral expression of mesolimbic dopamine stimulation in the rat. Neurosci. Lett. 50:1984;19-24.
283. Taber M.T., Fibiger H.C. Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors. J. Neurosci. 15:1995;3896-3904.
284. Tanner T. GABA-induced locomotor activity in the rat after bilateral injection into the ventral tegmental area. Neuropharmacology. 18:1979;441-446.
285. Terwilliger R., Beitner-Johnson D., Svarino K.A., Crain S.M., Nestler E.J. A general role for adaptiations in G-proteins and cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548:1991;100-110.
286. Tilson H.A., Rech R.H. Conditioned drug effects and absence of tolerance to d-amphetamine induced motor activity. Pharmacol. Biochem. Behav. 1:1973;149-153.
287. Timmerman W., Westerink B.H.C. Extracellular γ-aminobutyric acid in the substantia nigra reticulata measured by microdialysis in awake rats: effects of various stimulants. Neurosci. Lett. 197:1995;21-24.
288. Tong Z.-Y., Overton P.G., Clark D. Chronic admnistration of (+)-amphetamine alters the reactivity of midbrain dopaminergic neurons to prefrontal cortex stimulation in the rat. Brain Res. 674:1995;63-74.
289. Tong Z.-Y., Overton P.G., Clark D. Stimulation of the prefrontal cortex in the rat induces patterns of activity in midbrain dopaminergic neurons which resemble natural burst events. Synapse. 22:1996;195-208.
290. 3H]dopamine uptake in rat striatum: possible inolvement of calmodulin-dependent kinases. J. Neurochem. 65:1995;2065-2071.
291. Unterwald E.M., Cox B.M., Kreek M.J., Cote T.E., Izenwasser S. Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity. Synapse. 15:1993;33-38.
292. Unterwald E.M., Ho A., Rubenfeld J.M., Kreek M.J. Time course of the development of behavioral sensitization and dopamine receptor up-regulation during binge cocaine administration. J. Pharmacol. Exp. Ther. 270:1994;1387-1397.
293. Valadez A., Schenk S. Persistence of the ability of amphetamine preexposure to facilitate acquisition of cocaine self-administration. Pharmacol. Biochem. Behav. 47:1994;203-205.
294. 1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J. Neurosci. 16:1996;2411-2420.
295. Vezina P., Blanc G., Glowinski J., Tassin J.-P. Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbens. Synapse. 16:1994;104-112.
296. Wall S.C., Gu H., Rudnick G. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Mol. Pharmacol. 47:1995;544-550.
297. Wang J.Q., McGinty J.F. Alterations in striatal zif/268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in the rat. Brain Res. 673:1995;262-274.
298. Warburton E.C., Mitchell S.N., Joseph M.H. Calcium dependence of sensitised dopamine release in the rat nucleus accumbens following amphetamine challenge: implications for the disruption of latent inhibition. Behav. Pharmacol. 7:1996;119-129.
299. Weiss F., Paulus M.P., Lorang M.T., Koob G.F. Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels: effects of acute and repeated administration. J. Neurosci. 12:1992;4372-4380.
300. Weiss S.R.B., Post R.M., Pert A., Woodward R., Murman D. Context-dependent cocaine sensitization: differential effect of haloperidol on development versus expression. Pharmacol. Biochem. Behav. 34:1989;655-661.
301. Westerink B.H.C. Brain microdialysis and its application for the study of animal behaviour. Behav. Brain Res. 70:1995;103-124.
302. White F.J., Hu X.-T., Zhang X.-F., Wolf M.E. Repeated admnistration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J. Pharmacol. Exp. Ther. 273:1995;445-454.
303. White F.J., Wang R.Y. Electrophysiological evidence for A10 dopamine autoreceptor sensitivity following chronic d-amphetamine treatment. Brain Res. 309:1984;283-292.
304. F.J. White, Y.-H. Xiu, D.J. Henry, X.-F. Zhang, Neurophysiological alterations in the mesocorticolimbic dopamine system during repeated cocaine administration, in: R. Hammer (Ed.), The Neurobiology of Cocaine Addiction, CRC Press, Boca Raton, FL, 1995, pp. 99-120.
305. White F.J., Zhang X.-F. Repeated cocaine administration decreases whole-cell sodium current in acutely dissociated nucleus accumbens neurons. Soc. Neurosci. Abstr. 26:1996;1880.
306. Wightman R.M., Zimmerman J.B. Control of dopamine exracellular concentration in rat striatum by impulse flow and uptake. Brain Res. Rev. 15:1990;135-144.
307. Wilcox R.A., Robinson T.E., Becker J.B. Enduring enhancement in amphetamine-stimulated striatal dopamine release in vitro produced by prior exposure to amphetamine or stress in vivo. Eur. J. Pharmacol. 124:1986;375-376.
308. Will B.E., Toniolo G., Brailowsky S. Unilateral infusion of GABA and saline into the nucleus basalis of rats. 1. Effects on motor function and brain morphology. Behav. Brain Res. 452:1988;203-213.
309. Williams G.V., Goldman-Rakic P.S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature (London). 376:1995;572-575.
310. Williams J.E.G., Wieczorek W., Willner P., Kruk Z.L. Parametric analysis of the effects of cocaine and cocaine pretreatment on dopamine release in the nucleus accumbens measured by fast cyclic voltammetry. Brain Res. 678:1995;225-232.
311. Wilson J.M., Levey A.I., Bergeron C., Kalasinski K., Ang L., Peretti F., Adams V.I., Smialek J., Anderson W.R., Shannak K., Deck J., Niznik H.B., Kish S.J. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Annals Neurol. 40:1996;428-439.
312. 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. J. Neurosci. 14:1994;2966-2979.
313. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.
314. Wolf M.E., White F.J., Nassar R., Brooderson R.J., Khansa M.R. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264:1993;249-255.
315. Wright C.I., Beijer V.J., Groenewegen H.J. Basal amygadaloid complex afferents to the rat nucleus accumbens are compartmentally organized. J. Neurosci. 16:1996;1877-1893.
316. Wright C.I., Groenewegen H.J. Patterns of convergence and segregation in the medial nucleus accumbens of the rat: relationships of prefrontal cortical,midline thalamic, and basal amygdaloid afferents. J. Comp. Neurol. 361:1995;383-403.
317. Xia Y., Goebel D.J., Kapatos G., Bannon M.J. Quantitation of rat dopamine transporter mRNA: effects of cocaine treatment and withdrawal. J. Neurochem. 59:1992;1179-1182.
318. Xue C.-J., Ng J.P., Li Y., Wolf M.E. Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens. J. Neurochem. 67:1996;352-363.
319. Yang C.R., Seamans J.K. Dopamine D1 receptor actions in layer V-VI rat prefrontal cortex neurons in vitro: modulations of dendritic-somatic signal integration. J. Neurosci. 16:1996;1922-1935.
320. 2 autoreceptors. Pharmacol. Biochem. Behav. 36:1990;457-461.
321. 3H]Dopamine. Neuropharmacology. 29:1990;475-486.
322. Young D., Scoville W.B. Paranoid psychosis in narcolepsy and the possible dangers of benzedrine treatment. Medical Clinics of North America, Boston. 22:1938;637-640.
323. Young S.T., Porrino L.J., Iadorola M.J. Cocaine induces striatal c-Fos-immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl. Acad. Sci. (USA). 88:1991;1291-1295.
324. Youngren K.D., Daly D.A., Moghaddam B. Distinct actions of endogenous excitatory amino acids on the outflow of dopamine in the nucleus accumbens. J. Pharmacol. Exp. Ther. 264:1993;289-293.
325. Zahm D.S. The ventral striatopallidal parts of the basal ganglia in the rat. II. Compartmentation of ventral pallidal efferents. Neuroscience. 30:1989;33-50.
326. Zahm D.S., Brog J.S. On the significance of subterritories in the 'accumbens' part of the rat ventral striatum. Neuroscience. 50:1992;751-767.
327. Zahm D.S., Zaborszky L., Alones V.E., Heimer L. Evidence for the coexistence of glutamate decarboxylase and met-enkephalin immunoreactivities in axon terminals of rat ventral pallidum. Brain Res. 325:1985;33-50.
328. X.-F. Zhang, X.-T. Hu, F.J. White, M.E. Wolf, Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors, J. Pharmacol. Exp. Ther., 281 (1997).
329. Zhang Y., Angulo J.A. Contrasting effects of repeated treatment vs. withdrawal of methamphetamine on tyrosine hydroxylase messenger RNA levels in the ventral tegmental area and substantia nigra zona compacta of the rat brain. Synapse. 24:1996;218-223.